Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,259 | -64,539 | -33,914 | -13,149 | -35,129 |
| Depreciation Amortization | 344 | 328 | 269 | 135 | 169 |
| Income taxes - deferred | 165 | 34 | 24 | 8 | 114 |
| Accounts payable and accrued liabilities | -146 | 191 | 2,083 | 398 | -163 |
| Other Working Capital | 3,841 | 3,665 | 4,811 | 1,197 | -126,319 |
| Other Operating Activity | 22,597 | 23,109 | 5,880 | 1,954 | 112,272 |
| Operating Cash Flow | $-51,458 | $-37,212 | $-20,847 | $-9,457 | $-49,056 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -113,720 | -94,621 | -70,860 | N/A | N/A |
| Sale Of Investment | 32,000 | 10,500 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 356 |
| Investing Cash Flow | $-81,720 | $-84,121 | $-70,860 | $N/A | $356 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,559 | 14,410 | 40 | N/A | 69,443 |
| Other Financing Activity | -972 | -510 | -509 | 0 | 106,406 |
| Financing Cash Flow | $14,587 | $13,900 | $-469 | $N/A | $175,849 |
| Beginning Cash Position | 134,696 | 134,696 | 134,696 | 134,696 | 7,547 |
| End Cash Position | 16,105 | 27,263 | 42,520 | 125,239 | 134,696 |
| Net Cash Flow | $-118,591 | $-107,433 | $-92,176 | $-9,457 | $127,149 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,458 | -37,212 | -20,847 | -9,457 | -49,056 |
| Free Cash Flow | -51,458 | -37,212 | -20,847 | -9,457 | -49,056 |